| Dr Tom Kornhauser, MD | |
|
4301 W Markham St # 523, Little Rock, AR 72205-7101 | |
| (501) 686-5852 | |
| (501) 686-8560 |
| Full Name | Dr Tom Kornhauser |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 13 Years |
| Location | 4301 W Markham St # 523, Little Rock, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114656485 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207WX0200X | Ophthalmology - Ophthalmic Plastic And Reconstructive Surgery | E-15092 (Arkansas) | Secondary |
| 207W00000X | Ophthalmology | E-15092 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Uams Medical Center | Little rock, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Arkansas | 4082528955 | 1121 |
News Archive
Researchers have developed a new mathematical model which helps characterize factors responsible for the emergence of new SARS-CoV-2 variants and their predominance.
Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European Medicines Agency has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of pancreatic cancer.
"African countries are most at risk of social unrest and famine stemming from food shortages and rising prices, according to risk advisory firm Maplecroft," Bloomberg Businessweek reports.
The Quantum Group, Inc. announced that the third version of PWeRTM (Personal Wellness electronic RecordTM), PWeR 3.0, has deployed according to schedule. PWeR is the one patient, one record™ medical record platform that the Company believes is a relevant and real solution to meet current federal healthcare mandates and stimulus programs.
Clinicians and patients alike will benefit as the Pathology and Laboratory Quality Center of the College of American Pathologists releases a new evidence-based guideline that tackles the complexities of reporting findings from bone marrow specimens.
› Verified 6 days ago
| Entity Name | University Of Arkansas For Medical Sciences |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588654016 PECOS PAC ID: 4082528955 Enrollment ID: O20031219000706 |
News Archive
Researchers have developed a new mathematical model which helps characterize factors responsible for the emergence of new SARS-CoV-2 variants and their predominance.
Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European Medicines Agency has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of pancreatic cancer.
"African countries are most at risk of social unrest and famine stemming from food shortages and rising prices, according to risk advisory firm Maplecroft," Bloomberg Businessweek reports.
The Quantum Group, Inc. announced that the third version of PWeRTM (Personal Wellness electronic RecordTM), PWeR 3.0, has deployed according to schedule. PWeR is the one patient, one record™ medical record platform that the Company believes is a relevant and real solution to meet current federal healthcare mandates and stimulus programs.
Clinicians and patients alike will benefit as the Pathology and Laboratory Quality Center of the College of American Pathologists releases a new evidence-based guideline that tackles the complexities of reporting findings from bone marrow specimens.
› Verified 6 days ago
| Entity Name | University Of Arkansas For Medical Sciences |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346230968 PECOS PAC ID: 4082528955 Enrollment ID: O20040115000431 |
News Archive
Researchers have developed a new mathematical model which helps characterize factors responsible for the emergence of new SARS-CoV-2 variants and their predominance.
Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European Medicines Agency has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of pancreatic cancer.
"African countries are most at risk of social unrest and famine stemming from food shortages and rising prices, according to risk advisory firm Maplecroft," Bloomberg Businessweek reports.
The Quantum Group, Inc. announced that the third version of PWeRTM (Personal Wellness electronic RecordTM), PWeR 3.0, has deployed according to schedule. PWeR is the one patient, one record™ medical record platform that the Company believes is a relevant and real solution to meet current federal healthcare mandates and stimulus programs.
Clinicians and patients alike will benefit as the Pathology and Laboratory Quality Center of the College of American Pathologists releases a new evidence-based guideline that tackles the complexities of reporting findings from bone marrow specimens.
› Verified 6 days ago
| Entity Name | Arkansas Childrens Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598773079 PECOS PAC ID: 2769477744 Enrollment ID: O20040419000796 |
News Archive
Researchers have developed a new mathematical model which helps characterize factors responsible for the emergence of new SARS-CoV-2 variants and their predominance.
Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European Medicines Agency has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of pancreatic cancer.
"African countries are most at risk of social unrest and famine stemming from food shortages and rising prices, according to risk advisory firm Maplecroft," Bloomberg Businessweek reports.
The Quantum Group, Inc. announced that the third version of PWeRTM (Personal Wellness electronic RecordTM), PWeR 3.0, has deployed according to schedule. PWeR is the one patient, one record™ medical record platform that the Company believes is a relevant and real solution to meet current federal healthcare mandates and stimulus programs.
Clinicians and patients alike will benefit as the Pathology and Laboratory Quality Center of the College of American Pathologists releases a new evidence-based guideline that tackles the complexities of reporting findings from bone marrow specimens.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tom Kornhauser, MD 4301 W Markham St # 783, Little Rock, AR 72205-7101 Ph: (501) 686-8000 | Dr Tom Kornhauser, MD 4301 W Markham St # 523, Little Rock, AR 72205-7101 Ph: (501) 686-5852 |
News Archive
Researchers have developed a new mathematical model which helps characterize factors responsible for the emergence of new SARS-CoV-2 variants and their predominance.
Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European Medicines Agency has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of pancreatic cancer.
"African countries are most at risk of social unrest and famine stemming from food shortages and rising prices, according to risk advisory firm Maplecroft," Bloomberg Businessweek reports.
The Quantum Group, Inc. announced that the third version of PWeRTM (Personal Wellness electronic RecordTM), PWeR 3.0, has deployed according to schedule. PWeR is the one patient, one record™ medical record platform that the Company believes is a relevant and real solution to meet current federal healthcare mandates and stimulus programs.
Clinicians and patients alike will benefit as the Pathology and Laboratory Quality Center of the College of American Pathologists releases a new evidence-based guideline that tackles the complexities of reporting findings from bone marrow specimens.
› Verified 6 days ago
Robert Lowery, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St # 783, Little Rock, AR 72205 Phone: 501-686-8000 | |
Lydia F Lane, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9800 Lile Dr, Suite 400, Little Rock, AR 72205 Phone: 501-224-5658 Fax: 501-224-8114 | |
Dr. David R Rozas, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5300 W. Markham, Little Rock, AR 72205 Phone: 501-664-5354 Fax: 501-664-5257 | |
Ammar N Safar, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 4301 W Markham St, 523, Little Rock, AR 72205 Phone: 501-686-5150 Fax: 501-526-6562 | |
Dr. Jennifer Anderson, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 4301 W Markham St # 783, Little Rock, AR 72205 Phone: 501-686-8000 | |
Monica Verma, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 11825 Hinson Rd Ste 103, Little Rock, AR 72212 Phone: 501-747-1625 Fax: 501-747-1626 |